Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine
- 1 July 1987
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 61 (7) , 2150-2154
- https://doi.org/10.1128/jvi.61.7.2150-2154.1987
Abstract
Intragastric inoculation with whole-virion vaccine of inactivated influenza virus resulted in production of hemagglutinin (HA)-specific immunoglobulin A (IgA) and IgG both in lung lavage fluids and in serum samples of mice. HA-specific IgA was the predominant isotypic antibody secreted in the lung lavage fluids (average IgA/IgG ratio, 13:1), whereas HA-specific IgG was the major antibody class in serum (average IgA/IgG ratio, 0.3:1). These responses were similar to the antibody responses stimulated by intranasal infection with live influenza virus. In vitro cultures of lymphoid cells from lungs and Peyer's patches, but not from spleens, in the presence of homologous antigen, from mice vaccinated intragastrically synthesized mostly HA-specific IgA. Mice immunized parenterally with inactivated influenza virus produced only IgG in lung lavage fluids and sera. Cultures of lymphoid cells from their spleens, but not their lungs, synthesized HA-specific IgG upon antigenic stimulation in vitro; neither synthesized IgA. These in vitro cell culture results, as well as the inverse relationship of IgA/IgG ratios in lung lavage fluids and sera, demonstrated that the IgA antibody in lung lavage fluids was actively synthesized locally in the lungs of intragastrically immunized mice. This finding was consistent with the migratory distribution of antigen-primed lymphoid cells from Peyer's patches to distant lymphoid tissue such as lung. Intragastric vaccination conferred protection against intranasal challenge with a lethal dose of virulent virus.This publication has 31 references indexed in Scilit:
- Antibody in Tears, Saliva and Nasal Secretions Following Oral Immunization of Humans with Inactivated Influenza Virus VaccineInternational Archives of Allergy and Immunology, 1985
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981
- Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagentsJournal of Biological Standardization, 1980
- ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITALThe Lancet, 1979
- An Attenuated Influenza Virus Vaccine: Reactogenicity, Transmissibility, Immunogenicity, and Protective EfficacyThe Journal of Infectious Diseases, 1974
- VACCINATION IN THE CONTROL OF INFLUENZA: Interim Report to the Director of the Public Health Laboratory Service on a Collaborative Study with the Post OfficeThe Lancet, 1974
- The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccinesEpidemiology and Infection, 1973
- Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated VirusNature, 1968
- STUDIES IN EXPERIMENTAL IMMUNOLOGY OF INFLUENZAImmunology & Cell Biology, 1950